J3373 Injection, vancomycin hydrochloride, 10 mg

Billable / valid for submission HCPCS Release 2026Q3

Short description: Inj, vancomycin hcl, 10 mg

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, vancomycin hydrochloride, 10 mg	yes

J3300 Injection, triamcinolone acetonide, preservative free, 1 mg
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
J3302 Injection, triamcinolone diacetate, per 5 mg
J3303 Injection, triamcinolone hexacetonide, per 5 mg
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J3315 Injection, triptorelin pamoate, 3.75 mg
J3316 Injection, triptorelin, extended-release, 3.75 mg
J3350 Injection, urea, up to 40 gm
J3357 Ustekinumab, for subcutaneous injection, 1 mg
J3358 Ustekinumab, for intravenous injection, 1 mg
J3360 Injection, diazepam, up to 5 mg
J3374 Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg
J3375 Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mg
J3376 Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg
J3379 Injection, valproate sodium, 5 mg
J3380 Injection, vedolizumab, intravenous, 1 mg
J3385 Injection, velaglucerase alfa, 100 units
J3386 Injection, etuvetidigene autotemcel, per treatment
J3387 Injection, elivaldogene autotemcel, per treatment
J3389 Topical administration, prademagene zamikeracel, per treatment